Catholic University of the Sacred Heart-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2023

  1. Emerging Trends and Future Directions in Skin Cancer Management

    Non-melanoma Skin Cancer: Essentials for Oncologists (CRC Press), pp. 407-426

  2. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes

    The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106

  3. Interventional Radiotherapy (Brachytherapy) for the Treatment of Primary Lesions in Nasal Vestibule Malignancies

    Malignancies of the Nasal Vestibule: A New Perspective on Classification, Staging, and Treatment (Springer International Publishing), pp. 135-144

2022

  1. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy

    Radiotherapy and Oncology, Vol. 170, pp. 159-164

2021

  1. Response to Escande et al.: Magnetic guided brachytherapy: Time for non-pelvic cancer? Example from tongue brachytherapy [1]

    Radiotherapy and Oncology

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  2. Ethical criteria for the admission and management of patients in the icu under conditions of limited medical resources: A shared international proposal in view of the covid-19 pandemic

    Frontiers in Public Health, Vol. 8

  3. Recent Advancements in Hematology: Knowledge, Methods and Dissemination, Part 1

    HEMATO

2019

  1. Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): Single institution experience and systematic literature review

    Journal of Contemporary Brachytherapy, Vol. 11, Núm. 1, pp. 54-60

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

2014

  1. The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer

    Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119